Rheumatologe

Blog von Dr. med. Lothar M. Kirsch / 祁建德 // Poetry / Travels / Languages / Rheumatic Diseases / Tea

Seiten / Pages

▼
Showing posts with label MAB. Show all posts
Showing posts with label MAB. Show all posts
Friday, June 28, 2019

Lutikizumab in Osteoarthritis

›
Lutikizumab (ABT-981) is an anti-interleukin-1 α / β (anti-IL-1 α / β ) dual variable domain immunoglobulin. I’ve once discussed...
Thursday, January 17, 2019

Mavrilimumab discontinued

›
Adisinsight updated its information on Mavrilimumab on Dec. 12 th 2018. I’ve just checked this source as I wanted to know more ab...
Saturday, May 5, 2018

The Mystery of Vobarilizumab (ALX-0061) 2nd Part

›
If you look for vobarilizumab at the ACR, the last publication has been at the 2014 meeting [1]. The conclusion had been: “ALX-0061...
Saturday, June 17, 2017

Sarilumab (ALX-0061) at the 2017 EULAR Annual Meeting in Madrid

›
My first encounter with sarilumab has been in 2011 at the ACR Annual Meeting in Chicago [1]. I had been quite disappointed at the...
›
Home
View web version

Über mich / About myself / 自己的介绍

Rheumatologe
View my complete profile
Powered by Blogger.